A Trial Investigating the Pharmacodynamic Properties of NN1250 in Japanese Subjects With Type 2 Diabetes.
Phase of Trial: Phase I
Latest Information Update: 26 Nov 2013
At a glance
- Drugs Insulin degludec (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- 04 Jan 2012 Planned end date changed from 1 May 2012 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 04 Jan 2012 Actual patients number (1) added as reported by ClinicalTrials.gov.
- 04 Jan 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.